Fortress Biotech, Inc. vs. Johnson & Johnson
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| FBIO | JNJ | |
|---|---|---|
| Market Cap | $92.68 million | $620.77 billion |
| Revenue (TTM) | $66.16 million | — |
| Net Income (TTM) | $128.94 million | — |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| FBIO | JNJ | |
|---|---|---|
| P/E Ratio | 0.88 | — |
| Price / Book | 0.46 | — |
| Price / Sales | 1.40 | — |
FBIO and JNJ split the valuation factors evenly.
Profitability
| FBIO | JNJ | |
|---|---|---|
| Net Margin | 194.89% | — |
| Return on Equity | 63.71% | — |
FBIO and JNJ split the profitability factors evenly.
Risk & Sentiment
| FBIO | JNJ | |
|---|---|---|
| Short Interest | 3.18% | 0.67% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: FBIO overview, FBIO financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.